XENON PHARMACEUTICALS INC (XENE)

CA98420N1050 - Common Stock

43  +0.51 (+1.2%)

After market: 43 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.009.43M18.44M32.17M6.83M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
214.05M138.58M97.43M63.47M49.65M
Research and Development
167.51M105.77M75.46M50.52M38.85M
Selling, General, and Administrative Expenses
46.54M32.81M21.97M12.94M10.80M
Operating Income
-214.05M-129.14M-78.99M-31.30M-42.82M
Interest Income/Expense
31.37M3.89M110.00K3.20M1.20M
Non Recurring Items
N/A0.000.00-990.00KN/A
Income Before Taxes
-182.69M-125.26M-78.89M-29.09M-41.62M
Income Tax
-292.00K120.00K-10.00K-260.00K-20.00K
Net Income
-182.39M-124.94M-77.09M-28.01M-40.03M
EBITDA
-210.51M-127.52M-78.08M-30.66M-42.39M
 
Per Share Data
EPS Diluted Total Ops
-2.73-2.06-1.77-0.81-1.54
Non GAAP EPS
-2.72-2.04-1.77-0.81-1.54
 
Statistics
Profit Margin
N/A-1324.92%-418.06%-87.07%-586.09%
Operating Profit Margin
N/A-1369.46%-428.36%-97.30%-626.94%

All data in USD

Charts